Evercore ISI analyst Durgesh Chopra maintained a Buy rating on Edison International (EIX – Research Report) today and set a price target of ...

Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Walgreens Boots Alliance (WBA) to $12 from $9 and keeps an In Line ...

Evercore ISI upgraded shares of AON (NYSE:AON – Free Report) from an in-line rating to an outperform rating in a research report sent to investors on Wednesday morning, Ratings reports. The firm ...

Julian Emanuel of Evercore ISI says Trump's economic policies will be moderated and influenced by the bond markets. His does not see a significant downturn in the U.S. economy, explaining his S&P500 ...

Fintel reports that on January 7, 2025, Evercore ISI Group upgraded their outlook for Labcorp Holdings (NYSE:LH) from In-Line ...

On Tuesday, Evercore ISI analysts downgraded Dentsply Sirona stock from Outperform to In Line, adjusting the price target to $20.00. The decision was influenced by uncertainties surrounding the ...

Evercore ISI analysts updated their “AI Enablers, Adopters and Adapters” stock list. These stocks are screened from the Russell 3000 (IWV). They have a market cap of more than $3B and more ...

Evercore ISI analyst Chris McNally raised the firm’s price target on Tesla (TSLA) to $275 from $195 and keeps an In Line rating on the shares. Consistent with the firm’s valuation approach of ...

Globe Life (NYSE:GL – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” ...

On Tuesday, Evercore ISI raised its rating on Cardinal Health (NYSE:CAH) shares from In Line to Outperform, maintaining a price target of $140.00. The company, currently trading near its 52-week ...

On Tuesday, Evercore ISI raised its rating on Cardinal Health (NYSE:CAH) shares from In Line to Outperform, maintaining a price target of $140.00. The company, currently trading near its 52-week high ...

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.